bpc-157 legal status FDA Approval Status: Is It Approved for Human Use? BPC-157: A Prohibited Peptide and
Description
Gastrointestinal tract healing, lessons from tendon, ligament, muscle and bone healing. Current Pharmaceutical Design 24 (2018): 19721989
It has both protective and anti-inflammatory effects
BPC-157, known for modulating cytokine levels and inhibiting inflammatory enzymes, may work synergistically with Osthole and 5a-hydroxy laxogenin to reduce pro-inflammatory mediators
We propose a predisposition to tissue fragility in patients with clEDS, in particular of the gastrointestinal tract and emphasize the importance of counseling with regard to the risk of gastrointestinal complications
